[Effects of buspirone on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Krupina
N A
NA
Kryzhanovskiĭ
G N
GN
Orlova
I N
IN
Iordanskaia
T E
TE
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001522:Behavior, Animal / Q000187:drug effects*; D002065:Buspirone / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000139:chemically induced / Q000517:prevention & control*; D015259:Dopamine Agents / Q000633:toxicity*; D020267:MPTP Poisoning; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D015259:Dopamine Agents; D017366:Serotonin Receptor Agonists; D002065:Buspirone
Effekty buspirona na proiavleniia éksperimental'nogo depressivnogo sindroma u krys, vyzvannogo sistemnym vvedeniem 1-metil-4-fenil-1,2,3,6-tetragidropiridina (MFTP).